Evidence map›Paper›PMID 39289353›Full record

ArticleNature communications2024

Mechanistic analysis of Riboswitch Ligand interactions provides insights into pharmacological control over gene expression.

Shaifaly Parmar, Desta Doro Bume, Colleen M Connelly, Robert E Boer, Peri R Prestwood, Zhen Wang, Henning Labuhn, Krishshanthi Sinnadurai, Adeline Feri, Jimmy Ouellet and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Comparative Evaluation of Explicit Solvent Models for RNA-Ligand Docking.Journal of chemical information and modeling · 2026
    Article
  4. Article
  5. Article
  6. Biomolecular NMR assignments · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. RNA folding kinetics control riboswitch sensitivity in vivo.bioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Shaifaly ParmarChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Desta Doro BumeChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Colleen M ConnellyChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0003-1671-3243
Robert E BoerChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Peri R PrestwoodChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Zhen WangDepixus SAS, Paris, France.
Henning LabuhnDepixus SAS, Paris, France.
Krishshanthi SinnaduraiDepixus SAS, Paris, France.
Adeline FeriDepixus SAS, Paris, France.
Jimmy OuelletDepixus SAS, Paris, France.
Philip HomanCenter for Cancer Research Collaborative Bioinformatics Resource, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Tomoyuki NumataDepartment of Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, Fukuoka, Japan.
John S SchneeklothChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. schneeklothjs@mail.nih.gov.ORCID 0000-0001-7459-783X

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Identification of Nucleic Acid Binding Small MoleculesZIABC011585 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SCHNEEKLOTH, JOHN · 2014 to 2025
$18.6M
Intramural NIH HHS ZIA BC011585NCI NIH HHS 75N91019D00024U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) BC011585
6 · The paper itself

Abstract

Riboswitches are structured RNA elements that regulate gene expression upon binding to small molecule ligands. Understanding the mechanisms by which small molecules impact riboswitch activity is key to developing potent, selective ligands for these and other RNA targets. We report the structure-informed design of chemically diverse synthetic ligands for PreQ

Indexed as

Nucleic Acid ConformationRiboswitchThermoanaerobacterAptamers, NucleotideBinding SitesCrystallography, X-RayGene Expression Regulation, BacterialKineticsLigandsModels, MolecularRNA, BacterialAptamers, NucleotideLigandsRiboswitchRNA, Bacterial

Identifiers

PMID39289353
PMCPMC11408619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.